National Malaria Control Programme, Federal Ministry of Health, ElQasr Avenue, Khartoum, Sudan.
Malar J. 2024 Aug 27;23(1):259. doi: 10.1186/s12936-024-05090-y.
Malaria continues to cause high levels of morbidity and mortality despite concerted efforts to control the disease. The global burden is predominantly shouldered by countries in which the disease is highly endemic. In juxtaposition, the majority of evidence on progress towards malaria elimination has been documented in countries where baseline transmission was low. A notable exception is the People's Republic of China, in which the last indigenous case of malaria was recorded in 2016 after reporting over 30 million cases across various transmission strata in 1949. This review examined the extent, range, and nature of the literature addressing key contributors to malaria elimination in China. PubMed, Embase, Web of Science, ProQuest, Google Scholar and the WHO website were searched for relevant articles, and the JBI guidelines were followed for evidence selection, data extraction, and presentation of findings. The 17 articles that satisfied the eligibility criteria demonstrated the centrality of high-level political commitment in the elimination of malaria in China. The national malaria strategy was regularly updated to reflect evolving priorities, and the health system building blocks were strengthened to meet strategic targets. A whole-of-society approach to malaria was adopted, with intersectoral, interprovincial, regional, international, and community-mobilizing collaboration mechanisms established. Collaboration with academic institutions resulted in advantageous discoveries such as artemisinin, the current global gold standard for the treatment of malaria. The impact of malaria-specific interventions was augmented by China's economic growth. The findings of the review highlight the importance of adopting a comprehensive approach to malaria control that addresses the structural determinants of ill-health alongside downstream interventions.
尽管各国协同努力控制疟疾，但这种疾病仍然导致了高发病率和死亡率。疾病的全球负担主要由疾病高度流行的国家承担。相比之下，大多数关于消除疟疾进展的证据都记录在基线传播率较低的国家。一个显著的例外是中华人民共和国，1949 年报告了超过 3000 万例各种传播层次的疟疾病例后，于 2016 年记录了最后一例本土疟疾病例。本综述考察了中国消除疟疾的主要贡献者的文献的范围、范围和性质。检索了 PubMed、Embase、Web of Science、ProQuest、Google Scholar 和世界卫生组织网站上的相关文章，并遵循 JBI 指南进行证据选择、数据提取和结果呈现。符合资格标准的 17 篇文章表明，中国消除疟疾的关键是高层政治承诺。国家疟疾战略定期更新，以反映不断变化的优先事项，并加强卫生系统的组成部分，以实现战略目标。中国采取了全社会的疟疾防治方法，建立了部门间、省际、区域、国际和社区动员合作机制。与学术机构的合作带来了有利的发现，如青蒿素，这是目前治疗疟疾的全球黄金标准。疟疾特定干预措施的影响因中国的经济增长而增强。综述结果强调了采取综合疟疾控制方法的重要性，该方法既要解决健康不良的结构性决定因素，又要解决下游干预措施。
